Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Nanobiotix, an emerging nanomedicine company focused on cancer therapy, has elected Patrick Langlois as chairman of its non-executive board, effective immediately.
Subscribe to our email newsletter
Since March 1, 2005, Mr Langlois has served as a general partner with PJL CONSEILS, a consulting firm specializing in strategy, corporate development, and M&A activities for healthcare companies.
Prior to PJL, he was vice chairman of the management board and CFO at Aventis from May 2002 to September 2004, and executive vice president and CFO of Aventis from December 1999 to May 2002. At Aventis, Mr Langlois was responsible for finance, corporate development, and supervision of the company’s dermatology, protein therapeutics, and animal health businesses.
Laurent Levy, CEO of Nanobiotix, said: “We look forward to reaping the benefits of Patrick’s considerable talent and abundant experience related to accessing the capital markets and building strong strategic partnerships.”